Ameriprise
MBIO icon

Ameriprise’s Mustang Bio MBIO Stock Holding History

Ameriprise’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-22
Closed -$8K – 4013
2022
Q3 		$8K Sell
22
-40
-65% -$18.5K ﹤0.01% 3941
2022
Q2 		$27K Sell
62
-25
-29% -$13.8K ﹤0.01% 3848
2022
Q1 		$66K Buy
87
+17
+24% +$14K ﹤0.01% 3871
2021
Q4 		$87K Sell
70
-37
-35% -$59.7K ﹤0.01% 3879
2021
Q3 		$215K Sell
107
-2
-2% -$4.3K ﹤0.01% 3688
2021
Q2 		$272K Buy
109
+3
+3% +$7.35K ﹤0.01% 3683
2021
Q1 		$265K Buy
106
+68
+179% +$202K ﹤0.01% 3634
2020
Q4 		$103K Buy
+38
New +$90.8K ﹤0.01% 3686

Other funds holding MBIO

AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Ameriprise's MBIO Position: Q4 2022 in Review

Ameriprise sold out of Mustang Bio (MBIO) in Q4 2022, closing a stake of 22 shares — an estimated $8K sold.

Ameriprise first reported a position in MBIO in Q4 2020 and held it in 8 quarters. The position peaked at $272K in Q2 2021. 60 funds tracked by Wall St. Rank hold MBIO as of Q4 2022.

  • Ameriprise reported no remaining Mustang Bio position as of Q4 2022 after selling out during the quarter.
  • Ameriprise sold 22 Mustang Bio shares in Q4 2022, an estimated $8K.
  • Ameriprise first reported a position in Mustang Bio in Q4 2020 and held it in 8 quarters.
  • Ameriprise's Mustang Bio position peaked at $272K in Q2 2021.
  • 60 funds tracked by Wall St. Rank held Mustang Bio as of Q4 2022.

Based on Ameriprise's 13F filing for Q4 2022, filed 14 Feb 2023.